In addition, pharmacological “tool compound” inhibitors of LDH-A, GLS or lactate exporter MCT1 have been shown to inhibit MYC-dependent tumorigenesis in mouse models of cancer (Le et al., 2010, 2012; Wang et al., 2010; Doherty et al., 2014). Here, LDHA is linked to cancer.